This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Dr. Christopher Martin, PhD
Vice President of Manufacturing at Parabilis Medicines
Speaker

Profile

Chris Martin is the Vice President of Manufacturing at Parabilis Medicines, where he leads the global manufacturing network and oversees strategic planning for the supply of clinical and future commercial products. Prior to joining Parabilis, Chris worked in the CDMO sector, where he led teams focused on GMP peptide manufacturing, process development, scale-up, CMC activities, and process validation. He holds a Ph.D. in Chemistry from the Free University of Berlin, Germany, and completed his postdoctoral research at the Shanghai Institute of Organic Chemistry.

Agenda Sessions

  • CMC of Helicons™ - Helically Constrained Cell Permeable Peptides

    11:45am